GEODE CAPITAL MANAGEMENT, LLC
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,075,075
+2.4% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in APLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 2,075,075 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | — | 2,025,669 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | — | 2,072,913 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | — | 1,995,271 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | — | 1,950,046 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | — | 1,838,952 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | — | 1,810,526 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | — | 1,787,917 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | — | 1,689,890 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | — | 1,630,642 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | — | 1,554,826 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | — | 1,498,389 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | — | 1,838,279 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | — | 1,750,001 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | — | 1,691,202 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 1,610,162 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | — | 1,493,520 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | — | 1,352,829 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | — | 1,188,392 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | — | 1,118,135 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | — | 1,046,913 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | — | 936,533 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | — | 877,814 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | — | 865,898 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 828,049 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||